Share

String of Pearls: A Look at Rare Clinical Pearls from JCEM Case Reports

The JCEM Case Reports Clinical Pearls session at ENDO 2025 featured three presentations of rare challenging endocrine cases that could answer questions for endocrinologists who could be treating patients with similar symptoms, possibly triggering further investigations that might lead to optimal outcomes.  The audience for the third-annual JCEM Case Reports Clinical Pearls session at ENDO...
Share

An ENDO to Remember

Like many of you, I am still basking in the afterglow of yet another successful ENDO, as ENDO 2025 falls further and further away in the proverbial rearview mirror. Yes, I’m already anticipating ENDO 2026 in Chicago next June, but until that time, we have an issue packed with highlights from our standout event from...
Share

Staying in Control

A recent clinical trial reveals encouraging news for a Cushing’s disease treatment A poster from ENDO 2025 showed that osilodrostat provides sustained clinical benefits in Cushing’s patients who experienced positive outcomes by the end of the treatment period. Richard Auchus, MD, PhD, discusses how the data reinforces the drug’s use, which was well-tolerated for extended...
Share

AI in the Family

Revolutionary artificial intelligence applications transform endocrine disease detection and management Attendees at ENDO 2025 in San Francisco were all buzzing about the Elangovan family of Houston, Texas. That’s because high school-aged siblings, Ramya and Kavin, were presenting their research into how artificial intelligence (AI) could change the way certain endocrine disorders were diagnosed and treated....
Share

ENDO 2025: The Gold Standard

ENDO 2025 mines endocrine breakthroughs and breakouts in San Francisco When the biggest endocrinology conference in the world happens, professionals from around the world take notice! Over 7,000 endocrinologists hit the jackpot in San Francisco the second week in July for ENDO 2025 where there were more than just a few “eureka moments! People have...